论文信息 - Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study - 字舞流文

Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study

R. Fonseca | A. Krishnan | S. Trudel | J. Laubach | V. Choeurng | A. Lesokhin | S. Harrison | J. Richter | Sheeba K. Thomas | M. Mateos | A. Cohen | D. Samineni | L. Costa | Peter A Forsberg | A. Spencer | J. Berdeja | Chihunt Wong | T. Sumiyoshi | A. Vaze | J. Cooper | R. Kaedbey | Mengsong Li | P. Rodríguez-Otero